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Abstract
Individuals with epilepsy manage the clinical manifestations of the condition, primarily
seizure-related activity, with daily use of pharmacologic agents, making it one of the most
common neurological conditions treated with drug therapy for symptom management.
Pharmacologic agents for epilepsy, also known as anti-epileptic drugs (AEDs), are commonly
prescribed to treat seizures and neurologic conditions associated with epilepsy but can lead to a
reduced quality of life and many unwanted side effects. Complementary and alternative
treatments can also provide relief from seizures associated with epilepsy. The purpose of this
literature review was to evaluate the effectiveness of complementary and alternative treatments
compared to pharmacological treatment for individuals with epilepsy. A literature review
examining different alternative treatments, such as physical activity, medical cannabis,
neurostimulation, and various diets, and their benefits on seizure reduction, seizure frequency,
and the quality of life was conducted from various online databases. Research articles published
from 2003 to 2020 that focused on the benefits of complementary and alternative therapies in
controlling the clinical manifestations of epilepsy were included for synthesis. Results from 10
studies that used a complementary or alternative therapy as a treatment for epilepsy, alone or in
combination with pharmacological therapy, were compared for effectiveness on clinical
manifestations. Seventy percent of the studies analyzed show at least a fifty percent reduction in
seizure frequency. The studies suggest that complementary and alternative therapies can be
effective as monotherapy or as adjuvant agents for reducing seizure frequency, reducing seizure
duration, and improving quality of life. Although benefits were found in each study, many
studies were performed on animals or had small sample sizes, indicating the need for further
research.
iii

DEDICATION

For my family and close friends whose support has allowed me to be successful and grow as an
individual.

iv

ACKNOWLEDGMENTS

I would like to thank all of those who have guided me throughout the process of developing my
Undergraduate Honors Thesis, as well as throughout my endeavors in nursing school. I would
like to thank both of my sisters, Angela and Rachel, as well as my parents and my significant
other, Josh, for giving me support throughout this process. I would like to thank my thesis chair,
Dr. Leslee D’Amato-Kubiet, for her guidance and kindness throughout developing this review. I
would also like to thank my committee member, Dr. Angeline Bushy, for guidance throughout
this review. Thank you to the College of Nursing, faculty, and staff that have provided me with
an unforgettable and educational experience that I will take with me throughout the rest of my
nursing career. Finally, I would like to thank Burnett Honors College for their guidance while
developing my thesis.

v

Table of Contents
Introduction ................................................................................................................................................... 1
Background ................................................................................................................................................... 3
Problem ......................................................................................................................................................... 9
Purpose........................................................................................................................................................ 10
Method ........................................................................................................................................................ 11
Results ......................................................................................................................................................... 12
Ketogenic Diet ........................................................................................................................................ 12
Neurostimulation..................................................................................................................................... 14
Physical Activity ..................................................................................................................................... 16
Medical Cannabis and CBD.................................................................................................................... 18
Discussion ................................................................................................................................................... 20
Limitations .............................................................................................................................................. 23
Implications for Nursing ......................................................................................................................... 24
Table of Evidence ....................................................................................................................................... 25
References ................................................................................................................................................... 31

vi

Introduction
Epilepsy affects nearly 50 million individuals worldwide and is one of the most common
neurological conditions in world populations (Farrukh et al., 2020). Although there is no cure for
epilepsy, there are many prescriptive pharmacologic agents, known as antiepileptic drugs
(AEDs), that help individuals manage the clinical manifestations of the condition. There are
more than 20 AEDs currently available for the management of clinical manifestations associated
with epileptic related neurologic events (Cross, 2004). To determine which AED is appropriate,
variables, such as age, sex, and comorbid conditions, are considered when selecting an agent for
monotherapy or combined therapy, often used in severe cases unresponsive to monotherapy.
Although AEDs are the first-line therapy for individuals with epilepsy, approximately 33% of
individuals with epilepsy continue to have seizures (Asadi-Pooya et al., 2019). Frequent seizures
and the use of multiple AEDs is associated reduced quality of life (Walker et al., 2012).
Complementary and alternative medicines (CAM) and herbal supplements can also be used for
the treatment of epilepsy, although their use and effectiveness in people with epilepsy is poorly
understood.
The use of CAM and the combination of CAM with traditional AEDs has dramatically
increased in recent years. Although prescriptive pharmacologic therapies are widely used for
people with epileptic events, the use of complementary or alternative therapies (CAM), such as
medical cannabis and other herbs, neurostimulation, the ketogenic diet, acupuncture, and
exercise, are not widely accepted by the general population or health care providers. A number
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of these therapies are used with or without prescriptive pharmacologic medications to treat
epilepsy effectively (Kneen & Appleton, 2006). Despite the rates for CAM therapies growing
rapidly, less is known about their effectiveness and their benefits or risks in providing relief of
symptoms to people with epilepsy, indicating the need for further research.
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Background
Epilepsy is a neurological condition defined as the occurrence of two or more
unprovoked and unpredicted seizures occurring more than 24 hours apart (Thijs et al., 2019).
Abnormal, excessive, or simultaneous electrical discharge of the cerebral cortex that causes a
transient occurrence of signs or symptoms is known as an epileptic seizure (Cross, 2004). This
activity ultimately results in altered behavior, sensation, consciousness, and awareness of an
individual. Epilepsy varies from person-to-person, with some seizures lasting only a couple of
seconds and others lasting minutes. Epilepsy is considered resolved for individuals who have an
age-dependent syndrome but have passed a certain age and are seizure-free and for individuals
who have been seizure free for 10 years with no antiseizure medications for 5 years. (Thijs et al.,
2019). The causes and comorbidities of epilepsy can be determined to provide care that is
holistic and allows for the best possible management of seizures.
Approximately 60% of cases of epilepsy do not have a known cause (cryptogenic
epilepsy) (Solomon & McHale, 2012). Seizures are thought to arise from one of five main
conditions: genetic (idiopathic epilepsy), metabolic or structural (symptomatic epilepsy),
inflammatory, or infectious. Altered sodium and glucose, phenylketonuria, drug poisoning, renal
failure, withdrawal from ETOH, and environmental factors can all cause metabolic-related
epilepsy (Alireza Zali et al., 2018). Epilepsy related to structural abnormalities could be a result
of traumatic brain injuries, congenital brain defects, and lesions on the brain (Alireza Zali et al.,
2018). Other causative conditions leading to seizures include genetic conditions, such as
tuberous sclerosis, and inflammatory and infections, such as cerebral vasculitis or meningitis
(Solomon & McHale, 2012).
3

Understanding different types of epileptic clinical manifestations is beneficial to
providing holistic and therapeutic care aimed at the prevention of seizures. Seizures are typically
divided into two different categories: generalized seizures, where the entire brain is affected by
electrical activity, or focal (partial) seizures, where seizures originate from one area of the brain
(Cross, 2004). The classification is further broken down into subcategories. Absence, myoclonic,
clonic, tonic, tonic-clonic, and atonic seizure are classified as generalized seizures. Absence
seizures provoke a ‘trace-like’ state which manifests as a blank state and a brief upward rotation
of the eyes lasting anywhere from 3 seconds to 30 seconds (Alireza Zali et al., 2018). An absence
seizure will end with three distinct clinical manifestations: mild eyelid clonus, loss of muscle
tone, and oral automatism (Alireza Zali et al., 2018). Myoclonic seizures are sudden, shock-like
twitches that typically occur upon waking up or before going to bed and result in a brief loss of
consciousness. Seizures often occur in clusters lasting from a few minutes to a few hours.
Repetitive, jerky movements across both sides of the body, along with the presence of clonic
movement of the chest and urinary incontinence characterize a clonic seizure (Alireza Zali et al.,
2018). A tonic seizure is characterized by rigid muscle contraction. Tonic-clonic seizures, also
known as the grand mal seizures, include two distinct phases: the tonic phase and the clonic
phase. The tonic phase leads to the contraction of the respiratory muscles, ultimately leading to
stridor and cyanosis, as well as urinary inconsistency and tongue bite (Alireza Zali et al., 2018).
Deep respirations, muscle relaxation, and altered level of consciousness are all associated with
the clonic phase (Alireza Zali et al., 2018). Classic clinical manifestations of an atonic seizure
include the sudden reduction of muscle tone or “drop attacks”, which can result in injuries
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(Cross, 2004). If a tonic-clonic seizure occurs longer than five minutes without recovery between
attacks, the seizure is considered status epilepticus and is a medical emergency.
The clinical manifestations that occur during a focal (partial) seizure correlate with the
location of the abnormal electrical activity and the actions of the brain occurring at the location.
For example, the temporal lobe is responsible for feelings, emotions, memories (Solomon &
McHale, 2012). Individuals with temporal lobe epilepsy often experience epigastric sensations,
such as butterflies in their stomach, odd smells or tastes, and altered level of consciousness after
a seizure has occurred (Solomon & McHale, 2012). Typically, temporal lobe epilepsy responds
well to pharmacologic therapies. The frontal lobe is responsible for cognitive functions,
voluntary movement, and speech. Although frontal-lobe epilepsy is also location-dependent,
strange movements, such as head turning and thrashing around, and impaired speech can occur
(Solomon & McHale, 2012). People with epilepsy experiencing sight-related symptoms, such as
rapid eye blinking and seeing patterns, flashing lights, or colors, are often diagnosed with
occipital-lobe epilepsy (Solomon & McHale, 2012). However, since seizures from the occipital
lobe can spread to another lobe and change the characteristics of the seizures, it is often
challenging to diagnose. Tingling, warmness, and other sensory symptoms are often associated
with parietal- lobe epilepsy. With this type of epilepsy, individuals commonly report their
extremities feeling bigger or smaller.
Pharmacologic therapies are commonly used to manage the clinical manifestations of
epilepsy, with the goal of eliminating seizures and minimizing side-effects affecting quality of
life. Over two dozen medications to treat the clinical manifestations of epilepsy are available
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worldwide, yet only 66% of individuals in high-income countries respond well to the
medications (Thijs et al., 2019). Antiepileptic drugs (AEDs) are divided into categories based on
their mechanism of action: sodium channel blockers, GABA-A receptor activators, NMDA
receptor blockers, AMPA receptor blockers, calcium channel blockers (including T-channel
blockers and N and L-calcium blockers), H-current modulators, and neuronal potassium channel
openers (Alireza Zali et al., 2018). Some pharmacologic therapies can be used for both
generalized and focal seizures, while others are for specific types of epilepsy. Individualized
therapeutic plans are formulated according to the individual’s age, sex, comorbidities, epilepsy
type, and tolerability, in order to reduce clinical manifestations of seizure activity. For example,
valproate and clonazepam are commonly used for the treatment of myoclonic seizures, while
absence seizures specifically respond well to ethosuximide, valproate, and clonazepam.
The failures of two antiseizure drug schedules to achieve adequate seizure freedom is
known as drug-resistant epilepsy. In individuals with epileptic related seizures do not respond
well to antiepileptic drugs (AEDs), non-pharmacological therapies, such as certain diets, Vagal
nerve stimulation, exercise, acupuncture, surgical operations, and medical cannabis are also
available (Kneen & Appleton, 2006). Diets such modified Atkins and ketogenic could improve
seizure control in some individuals. Vagal nerve stimulation (VNS), which is performed with a
neuro-stimulating device, has been approved by the Food and Drug Administration (FDA) for
the management of focal-onset epilepsy for those older than the age of 12 that are not fit
candidates for surgical operations (Alireza Zali et al., 2018). Surgical procedures, such as
anterior callosotomy, lesionectomy, focal resection, lobectomy, hemispherectomy, and multiple
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subpial transections have also proven to be effective for focal epilepsies, although they are not
the first-choice alternative therapy.
In addition to pharmacologic and non-pharmacologic drug therapies for epilepsy, herbal
therapies have also shown to be effective in the prevention of seizures. Up to 90% of individuals
with epilepsy in developing countries do not receive care for their condition, motivating
researchers to investigate the effect of plant-based therapeutics on seizure activity (Sucher &
Carles, 2015). Extracts, such as flavonoids, (furano) coumarins, phenylpropanoids, and
terpenoids, have been shown to exhibit anticonvulsant effects. Some plant extracts were reported
to have similar effects to that of synthetic drugs. For example, Aegle marmelos, Delphinium
denudatum, Ficus religiosa, and Nymphaea alba were reported to have an effect that is similar to
the AED phenytoin (Sucher & Carles, 2015).
Recent studies suggest medical cannabis provides people with epilepsy an alternative
treatment for seizures, resulting in improved cognitive and behavioral function and the reduction
of seizure frequency and intensity (Markle & Nativio, 2019). Medical cannabis could provide an
opportunity for nearly 470,000 Americans to benefit from a seizure-free life (Markle & Nativio,
2019). However, many of the herbal therapies have not been assessed for their efficiency, safety,
or cost-effectiveness. The Holistic Theory of Nursing provides guidelines for preparing an
individualized treatment plan that is both and tailored to the individual. Individual considerations
are a mainstay of therapy when developing a treatment plan.
To treat individuals with epilepsy effectively and therapeutically, planning involves
assessment of the individual’s financial situation, culture, age, medical history, religious beliefs,
7

and geographic location to the nearest pharmacy, market, and acute care facility. Holistic nursing
focuses on healing the person, rather than treating their clinical manifestations. In the holistic
nursing theory, healing is based on a person’s interconnectedness of the mind, spirit, body,
emotions, relationship, environment, and social interactions (Petiprin, 2020). The physical needs
of each individual, as well as their psychological and spiritual needs, are addressed in this theory,
allowing health care providers to develop a plan of care specific and detailed to each person’s
situation and clinical manifestations associated with epilepsy. The holistic theory allows
providers to build a stronger relationship with each individual with epilepsy and acts as a guide
to promote healing and health (Petiprin, 2020).
Epilepsy affects millions of individuals around the world. Nearly 30% of individuals with
epilepsy experience intractable epilepsy, where combination therapy of two or more drugs does
not show a therapeutic effect on an individual (Alqahtani et al., 2020). Uncontrolled epilepsy can
severely affect an individual’s quality of life. Although pharmacological therapies are common
for individuals with epilepsy, many alternative and complementary therapies, including medical
cannabis and other herbs, neurostimulation, the ketogenic diet, acupuncture, and exercise, have
also been proven to have significant therapeutic effects on the clinical manifestations of the
condition. Each therapy needs to be researched further to determine the effects it has on
individuals with epilepsy.
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Problem
The clinical manifestations of seizure activity in individuals with epilepsy are often
difficult to control. Although pharmacologic therapies are typically used to control signs and
symptoms associated with epilepsy, complementary and alternative therapies can be considered
when developing a treatment plan to prevent seizures from occurring. Complementary therapies,
such as electroconvulsive therapy, the ketogenic diet, acupuncture, exercise, and herbal
supplements, have not been widely researched. The use of complementary and alternative
therapies must be evaluated further to understand the effects they have on people with epilepsy.
The effects that complementary and alternative therapies, as well as the combination of
COM therapies with pharmacologic therapies in people with epilepsy is not fully understood.
Research demonstrates several alternative therapies can have a positive impact on clinical
manifestations of people with epilepsy, leading to a lifestyle free of seizure activity. However,
the research is vague and does not convey one therapy is more beneficial than another. Further
research is needed to understand complementary and alternative therapies and their effects on the
clinical manifestations of epilepsy, as well as the benefits each CAM can provide for the
different types of epilepsy.
Evidence suggests complementary and alternative therapies can be effective for treating
the clinical manifestations associated with epilepsy and can produce fewer side effects. Herbal
AED’s produce less side effects than pharmacological AED’s. Further research is needed to
address many unanswered questions concerning the effectiveness of each complementary and
alternative therapies in individuals with epilepsy.
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Purpose
The purpose of the literature review is to examine the risks and benefits of
complementary and alternative therapies in people diagnosed with epilepsy. Evidence showing
improvement in the clinical manifestations related to CAM used with epilepsy are sparse.
Additionally, knowledge about the combination of CAM with traditional AEDs on the clinical
manifestations associated with epilepsy indicates the need for further research into mechanisms
of action of CAM agents and dosing quantities to prevent harm. Most of the research conducted
is still experimental and focuses on neuropeptides interference, microRNA activity, and tools to
regulate electrical activity, rather than benefits of complementary therapies, such as alternative
diets, exercise, or herbal therapies. Alternative and complementary therapies for individuals with
epilepsy can be useful and a better understanding of the effects they have on preventing and
interrupting seizures would be of value to the individual with epilepsy and the healthcare
provider prescribing therapy.
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Method
A comprehensive review of the literature was performed using research articles available
from 2003 to 2020 regarding the use of complementary and alternative therapies and their
relationship in managing clinical manifestations associated with epilepsy. The focus was the use
of alternative therapies, such as herbal therapy for individuals with epilepsy. Databases used to
search for articles included EBSCO host databases, Medical Literature On-Line (Medline),
Cumulative Index to Nursing and Allied Health Literature (CINAHL), and PsychInfo databases.
Searches will use a combination of the following terms: Epilepsy*, seizure*, alternative*,
complementary*, clinical manifestations*, benefit*, therapies*, and, treatments*. Inclusion
criteria consisted of 1) published research in English, 2) complementary and alternative therapies
compared to prescriptive agents, and 3) complementary and alternative therapies used to control
clinical manifestations associated with epilepsy. Articles excluded focused solely on
pharmacological therapies available to individuals with epilepsy and treatments that did not
include the use of complementary and alternative therapies.
The data was compiled into tables to synthesize the relationship between the benefits of
complementary and alternative treatments in controlling the clinical manifestations of epilepsy.
Additional information on the benefits of complementary and alternative treatments was tabled
based on the information obtained. Data showed the evidence for the use of complementary and
alternative therapies on the clinical manifestations of the clinical manifestations in people with
epilepsy.
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Results
Twelve studies related to complementary and alternative therapies on the clinical
manifestations of epilepsy were included in the literature review. Of the twelve studies reviewed,
nine studies proved to be effective and three proved to be inconclusive. The studies suggest
complementary and alternative treatments can be effective treating the clinical manifestation of
epilepsy, however, the data was limited. Many of the studies included complementary and
alternative treatments in addition to pharmacological regimens, indicating adjuvant agents to
pharmaceutical drug therapy can control clinical manifestations associated with epilepsy. The
effectiveness of complementary and alternative therapy use alone for managing the clinical
manifestations associated with epilepsy is of value but poorly understood. Additionally, many
studies had small sample sizes, focused on an individual type of epilepsy, or used animal testing,
which did not translate to human variants.

Ketogenic Diet
The ketogenic diet has been widely studied as an alternative treatment in relation to
treating the clinical manifestations for individuals with epilepsy. The ketogenic diet is a diet
consisting of high fat, low carbohydrates, and moderate-protein intake (Baby, Vinayan,
Pavithran & Grace Roy, 2018). Rather than using glycolysis for energy, this diet shifts human
metabolism to use fatty acids and ketones (Roehl, Falco-Walter, Ouyang & Balabanov, 2019).
The majority of evidence supports that the ketogenic diet improves seizure frequency, as well as
seizure severity and overall quality of life. All four studies analyzed in the literature review were
shown to have a major impact on seizure frequency. Two studies focused on how the ketogenic
diet affects the clinical manifestations of adults with epilepsy, while the other study focused on
12

how the ketogenic diet impacts children with pharmco-resistant epilepsies. The other study
compared the ketogenic diet to other diets, including the modified Atkins diet and low Glycemic
Index Therapy diet (Sondhi, et al., 2020).
In one study, twenty-nine individuals (16 women and 13 men) between the ages of 11
and 51 were placed on the ketogenic diet with the ratio of 4 grams of fat to 1 gram of
carbohydrates and protein (Nei, Ngo, Sirven & Sperling, 2014). Of the twenty-nine individuals,
fifteen individuals had a reduction in their seizure frequency, with thirteen experiencing a seizure
reduction more than 50% and six experiencing a seizure reduction of more than 80% (Nei, Ngo,
Sirven & Sperling, 2014). Another study compared the quality of life in adults with epilepsy
following the modified ketogenic diet with 15 grams of carbohydrates daily (MKD-15) with
adults with epilepsy consuming 50 grams of carbohydrates daily (MKD-50). Out of the 55
participants who met criteria, 87% (n= 48) reported improvements in their quality of life and
60% (n= 33) reported having improvements in the seizure frequency (Roehl, Falco-Walter,
Ouyang & Balabanov, 2019), proving that the ketogenic diet is effective for both seizure
frequency as well as overall quality of life.
Another study focused on how the ketogenic diet affects Indian children with refractory
epilepsy and is limited in the amount of evidence it provides. Although the results show fortyfour out of the seventy-four children reported more than an 50% reduction in their seizure
frequency, this study was limited to children between the ages of 1 months to 13 years, only
included children with a certain ethnicity, and only included children with certain types of
seizures (Baby, Vinayan, Pavithran & Grace Roy, 2018). Although the majority of studies have
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shown beneficial effects of the ketogenic diet on the clinical manifestations associated with
epilepsy, further research is needed to confirm due to small sample sizes and the limited research
on the ketogenic diet in relation to specific types of seizures.

Neurostimulation
Approximately 30% of individuals with epilepsy experience drug resistant epilepsy
(DRE), leading to complications such as increased morality, decreased quality of life, and social,
work, and stigma problems (Gil-Lopez et al., 2020). Evidence supports that neurostimulation can
be an effective alternative for individuals with drug-resistant epilepsy, but data is limited. The
three studies analyzed included different types of neurostimulation- deep brain stimulation
(DBS), trigeminal nerve stimulation, and auricular vagus nerve stimulation. Out of the three
studies analyzed, two were shown to be an effective alternative treatment for individuals with
epilepsy and one study was shown to be inconclusive due to the small sample size and animal
testing. Two of the three studies involve invasive neurostimulation techniques (deep brain
stimulation and vagus nerve stimulation), while one study focused on a non-invasive
neurostimulation technique (external trigeminal nerve technique). Two studies focused on the
effects of neurostimulation on humans, while one focused on the effects of neurostimulation on
monkeys.
One study focused on the effects of external trigeminal nerve stimulation on individuals
older than the age of eighteen. External trigeminal nerve stimulation (ETNS) is a non-invasive
type of neurostimulation conducted with bilateral adhesive skin electrodes (Gil-Lopez et al.,
2020). In this study, twenty participants were randomly assigned in the external trigeminal nerve
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stimulation group and twenty participants were randomly assigned to the control group. After
one year of treatment, 10 participants (50%) in the ETNS group responded to treatment and 0%
in the control group responded to treatment (Gil-Lopez et al., 2020). Additionally, the ETNS
group showed a decrease by -41.79% from baseline in seizure frequency after 6 months of
treatment and -43.5% from baseline in seizure frequency after one year of treatment (Gil-Lopez
et al., 2020). Frontal lobe epilepsy was shown to be less responsive to treatment compared to
temporal lobe epilepsy.
Another study focused on the effects of transcutaneous auricular vagus nerve stimulation
for pediatrics with intractable epilepsy (He et al., 2013). Initially, fourteen participants began
transcutaneous auricular vagus nerve stimulation using a ear vagus nerve stimulator. Thirteen
participants completed the 24-week study without changing their pharmacological regimens. The
baseline seizure frequency was compared 8 weeks after undergoing treatment, 9 to 16 after
undergoing treatment, and 17 to 24 weeks after undergoing treatment. The results showed
reductions in seizure frequency during the three 8-week periods: 31.83% after 8 weeks, 54.13%
from weeks 9 to 16 and 54.21% from weeks 17 to 24 (He et al., 2013). Four out of the fourteen
participants responded to treatment during the first 8 weeks (28.57%) and seven out of the
thirteen participants responded to treatment during the second and third 8-week periods (53.85%)
(He et al., 2013). Figure 1 and 2 show the responder rate and the decrease in seizure frequency
experienced during this study. Another study determined that low frequency stimulation had a
stronger effect on the number of seizures than high frequency stimulations (Sherdil, Chabardes,
David, & Piallat, 2020). Data is limited within this study because of the small sample size (n= 3)
and animal testing.
15

Figure 1. Responder rate after 8, 16, and 24 weeks (He et al., 2013)

Figure 2. The decrease in seizure frequency (He et al., 2013)

Physical Activity
Although the number of clinical studies is limited, research over recent years has shown
physical activity is effective alternative therapy with beneficial effects for epilepsy. Clinical
research has found that regular exercise may reduce seizure frequency and increase
psychological and cardiovascular health in individuals with epilepsy (Campos et al., 2017). The
studies analyzed used Wistar rats as test subjects, proving both to be inconclusive. In one study,
the Wistar rats were divided into four different groups: control, epilepsy, epilepsy with forced
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exercise, and epilepsy with voluntary exercise (Campos et al., 2017). The seventy-one Wistar
rats were given 350 mg/kg of pilocarpine hydrochloride to induce seizures. Seizure frequency
was recorded during two different periods. During the first period, the observed number of
seizures was 9.50 for the epilepsy group, 8.93 for the epilepsy with forced exercise group, and
11.67 for the epilepsy with voluntary exercise group. During the second period, the observed
number of seizures was 6.86 for the epilepsy group, 6.60 for the epilepsy with forced exercise
group, and 4.25 for the epilepsy with voluntary exercise group (Campos et al., 2017). Figure 3
shows the decrease in the number of seizures from the first period to the second period between
epilepsy, epilepsy with forced exercise, and epilepsy with voluntary exercise groups. Another
study conducted on 20 Wistar rats also showed physical activity to have positive effects on
induced seizures. This study consisted of fifteen 3-day cycles- the rats would run on the treadmill
the first day, swim on the second day, and rest on the third day (Setkowicz & Mazur, 2006).
Results showed that the rats experienced decreased susceptibility to frequently induced seizures,
but is limited on the data it provides. Further research is needed to confirm that physical exercise
is beneficial to individuals with epilepsy due to small sample sizes and animal studies.
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Figure 3. Epilepsy with forced exercise, and epilepsy with voluntary exercise groups (Campos et al., 2017)

Medical Cannabis and CBD
Cannabis is the most widely studied herbal therapy in relation to treating the clinical
manifestations of epilepsy, however, mixed results regarding the effectiveness have been found.
Two components of Maijuana have shown to have anticonvulsant effects- non-psychoactive
cannabidiol (CBD) and psychoactive Δ9-tetrahydro-cannabinol (THC) (Hausman-Kedem,
Menascu, & Kramer, 2018). Most studies show that CBD has a greater role in reducing one’s
seizure frequency than THC. CBD is thought to have an antiepileptic mechanism by inhibiting
excitatory glyatmaterhia neurotransmission, although the mechanism is still unclear (HausmanKedem, Menascu, & Kramer, 2018).
In one study, 57 children and adolescents between the ages of 1 to 20 years with
refractory epilepsy were given Cannabis oil in addition to their other therapeutic therapies for at
least three months. Twenty out of the forty-six (43.5%) included for analysis, including two
participants that experienced seizure exacerbation, had a seizure reduction between 0 to 49%, ten
18

participants had a seizure reduction of 50 to 75%, fourteen participants had a seizure reduction of
75 to 99%, and two participants were completely seizure free (Hausman-Kedem, Menascu, &
Kramer, 2018). The results showed several participants experienced a significant reduction in
their seizure frequency (56.5%), while others did not (43.5%). Medical cannabis was proven to
be more effective in the younger ages group (<10 years) and those on a higher CBD dose. Nearly
50% participants experienced adverse reactions, which was the main reason for treatment
cessation (Hausman-Kedem, Menascu, & Kramer, 2018). Although the results suggest that
adding CBD-enriched medical cannabis to the daily pharmacological therapy can be effective for
children and adolescents, many components need to be explored further to determine cannabis’
true effectiveness in improving seizure frequency.
Another study focused on the efficacy of CBD added to antiepileptic drugs (AED) for the
treatment of seizures associated with Lennox-Gastaut syndrome, a severe form of epilepsy.
Participants between the ages of 2 and 55 years old were divided into two groups: one was
placed on a 20 mg/kg/ day oral solution of CBD and the other group had the matched placebo
(French et al., 2017). Each group was tolerated for 2 weeks, followed by a 12-week dose
maintenance. Although the results show a significant difference in seizure frequency between the
CBD group versus the placebo group (44% versus 22%), this study is limited because it only
focused on one type of epilepsy (French et al., 2017). Another study showed similarities, where
36.5% of individuals experienced a decrease in their seizure frequency and included epilepsies
with different causes (Devinsky et al., 2016). More research is needed to determine if CBD is
effective in all mild, moderate, and severe forms of epilepsy.
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Discussion
Studies examined in this thesis offer insight into complementary and alternative
treatments for the clinical manifestations of epilepsy. Research findings showed the benefits of
using complementary and alternative therapies for the clinical manifestations of epilepsy;
however, results were often mixed. Although many of the studies presented with limitations and
mixed results, the majority of the studies revealed positive effects complementary and alternative
therapies have in minimizing the clinical manifestations of epilepsy, making it an effective form
of treatment.
Pharmacologic treatments are often the first-choice therapy to treat the clinical
manifestations associated with epilepsy but can leave a negative impact on an individual’s
quality of life, sigma, relationships, and social life. Additionally, nearly 30% of individuals with
epilepsy on multiple antiepileptic drugs (AEDs) experience intractable epilepsy, where the
combination of two or more pharmacological drugs does not control their clinical manifestations
(Alqahtani et al., 2020). The side effects of many pharmacologic treatments and many
individuals not achieving seizure freedom on pharmacological treatments alone and exploring
other treatment options is essential. There are many non-pharmacological treatments available to
help with the clinical manifestations of epilepsy, including neurostimulation, the ketogenic diet,
medical cannabis, and physical activity. Complementary and alternative therapies open up a new
opportunity for individuals with epilepsy to achieve seizure freedom. More research is
imperative to help individuals eliminate seizures, while minimizing the side-effects affecting
quality of life.
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The studies analyzed offered a variety of different alternative and complementary
treatments available to individuals with epilepsy. More than 70% of the studies analyzed in this
literature review showed benefits in improving the seizure frequency and the clinical
manifestations associated with epilepsy. One study showed that CBD-enriched cannabis could be
a very promising alternative treatment for the clinical manifestations of epilepsy, with 56% of
participants experiencing a reduction in their seizure frequency (Hausman-Kedem, Menascu, &
Kramer, 2018). Two studies on CBD oral solution and cannabidiol proved to be effective for
reducing seizure frequency, however, less than 50% of the participants experienced a reduction
in their seizure frequency and many adverse effects were reported (Devinsky et al., 2016)
(French et al., 2017). One study compared the ketogenic diet to the modified Atkins diet and low
Glycemic Index Therapy diet for drug-resistant epilepsies and found that the ketogenic diet has
the biggest impact on seizure reduction (Sondhi, 2020). Additionally, some forms of
neurostimulation, including transcutaneous auricular vagus nerve stimulation, external trigeminal
nerve stimulation, and deep brain stimulation, has also proven to be effective on seizure
frequency, but data is limited (He et al., 2013) (Serdil, Chabardes, David, & Piallat, 2020) (GilLopez et al., 2020). Although many of the studies portrayed the same benefits with alternative
and complementary treatments, many had small sample sizes or were tested on animals,
indicating the need for further research.
Although many of the studies had limitations, this literature review provides information
on a variety of different alternative treatments that have shown positive effects on the clinical
manifestations associated with epilepsy. The studies show to have a positive effect on seizure
frequency, duration, and overall quality of life. Studies in the future should include a variety of
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different types of seizures, as well as a variety of different ages (children, adolescents, and
adults) should be put more into consideration. Some studies compared alternative therapies to a
placebo group to determine the effectiveness. These studies showed the benefits of alternative
therapies, but failed to show how effective they were compared to pharmacological therapies.
Comparing and contrasting pharmacological therapies to alternative and complementary
therapies may help prove how beneficial the alternative treatments can be.
Complementary and alternative therapies are becoming more and more popular and can
be used in a variety of different diseases. Many studies added complementary and alternative
therapies to pharmacological therapies and examined their effects. For example, one study added
CBD to participants' regular pharmacological therapies. The results showed a median seizure
frequency drop of 74 per month, proving that CBD is effective for seizure frequency when added
to AEDs (He et al., 2013). While this was proven to be effective, more studies need to focus on
alternative therapies alone.
In conclusion, there should be further studies on alternative and complementary
treatments used in controlling the clinical manifestation associated with epilepsy. Further studies
can help determine which CAM therapy is the most beneficial for which type of seizure, for
certain age groups, and in comparison, or in conjunction with pharmacological therapies. The
evidence presented supports that complementary and alternative therapies are effective in
treating the clinical manifestations associated with epilepsy. Therefore, these options should be
available and offered as a treatment option to individuals with epilepsy. Complications were
shown in two of the CBD studies, with more than 75% of participants reporting having adverse
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effects (French et al., 2017) (Devinsky et al., 2016). However, all the CBD studies still proved to
be effective in reducing seizure frequency. The majority of the studies analyzed showed positive
effects on managing the clinical manifestation of epilepsy, suggesting that individuals should use
CAM therapies to better manage their symptoms.

Limitations
This literature review contained several limitations. Several of the studies had small
sample sizes, were tested on animals, were compared to a placebo rather than pharmacological
agents, and were focused on a certain population, such as pediatrics or only individuals with
refractory epilepsy. A number of studies focused on the pediatric population alone, while others
included both the pediatric and adult population. Some studies focused on certain types of
epilepsy, such as a severe form of epilepsy, further limiting the data provided. Knowing which
alternative medicine is beneficial to which type of seizures is important to understand and is
something that can be researched further.
The sample sizes ranged from n= 3 to n =170. The smallest sample size group explored
deep brain stimulation on three monkeys (Sherdil, Chabardes, David, & Piallat, 2020). Although
the results showed that having a low frequency stimulation had a positive effect on seizure
frequency and duration, the reliability of the finding is limited due to the small sample size and
animal testing. The largest sample size group explored which diet was most beneficial for seizure
frequency: The Ketogenic diet, the Modified Atkins diet, or the Glycemic Index Therapy diet.
The ketogenic diet was shown to have the most positive effect on seizure frequency, with a 66%
reduction (Sondhi et al., 2020).

23

Three studies in this research were performed on monkeys or Wistar rats. Although all
three showed positive effects on clinical manifestation associated with epilepsy, the studies were
not performed on humans, making the results inconclusive. Further trials need to be performed
on humans to better understand the benefits that alternative and complementary therapies offer.
In addition to small sample sizes and animal studies, many of the alternative and complementary
treatments were compared to a placebo group, rather than pharmacological agents. Without
comparing alternative and complementary treatments to pharmacological agents, it can be
difficult to determine if the CAM therapies are as effective as the agents. Providing further
research comparing pharmacological therapies to CAM therapies would be beneficial in
determining which is best for treating certain types of seizures.

Implications for Nursing
Pharmacological agents often leave individuals with unwanted side effects, affecting their
overall quality of life. Many alternative and complementary therapies can offer individuals
seizure freedom without the effects of pharmacological treatments. Continuing research of the
alternative therapies for the clinical manifestations of epilepsy is imperative, so that individuals
can receive the greatest seizure reduction, with the least number of adverse effects. Individuals
with epilepsy should be educated on the various alternative therapies available as treatment
options for the clinical manifestations of epilepsy. Health care facilities should implement
alternative and complementary treatments for managing the clinical manifestations associated
with epilepsy. Further research is needed to understand the effectiveness of alternative and
complementary therapies in comparison to pharmacological therapies on the clinical
manifestation of epilepsy.
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Table of Evidence
Authors
Year

Study Purpose

Study description

Results

Nei, Ngo, Sirven,
& Sperling

To test the efficiency
of the ketogenic diet
in adults with
epilepsy

Total of 29 participants
included

Fifteen of the twentynine patients (52%)
experienced reduction
in seizure frequency
Thirteen patients (45%)
has a seizure reduction
more than 50%, with
21% of those
experiencing an 80%
reduction in their
seizure frequency

(2014)

Women= 16
Men= 13
Participants were placed
on ketogenic diet ratio of
4 grams of fat to one
gram of carbohydrates
and protein

Complementary or
alternative treatment
effectiveness
1= not useful
2= inconclusive
3= useful
3
More than half of the
participants in this study
had a reduction in their
seizure frequency
This study showed that
diets, such as the
ketogenic diet, can be
beneficial for controlling
epilepsy

Nine patients (31%) did
not have improvement
of their seizure
frequency, with three
experiencing a seizure
increase
HausmanKedem,
Menascu, &
Kramer

To evaluate the
efficiency of medical
cannabis for the
treatment of
refractory epilepsy

(2018)

Sherdil,
Chabardes,
David, & Piallat
(2020)

To evaluate whether
the frequency of
stimulation is an
important parameter

Total of 57 participants
included
The participants were
between the ages of 1 to
20 years old
Participants were treated
with Cannabis oil extract
with the CBD/THC ratio
of 20:1 for at least 90
days

Total of three monkeys
were tested in this study
One female monkey, two
male monkeys

Of the 57 participants,
only 46 were included
in the efficacy analysis.
20 participants had a
seizure reduction
between 0 to 49%, 10
participants had a
reduction of 50 to 75%,
14 participants had a
reduction of 75 to 99%,
and 2 were seizure free
Low frequency
stimulation was shown
to have a stronger
effect on the number
of seizures, as well as

3
Of the 46 participants
included in this study, 26
participants (56%)
experienced a reduction
in their seizure
frequency.
CBD-enriched cannabis
extract is a very
promising anti-seizure
option
2
This study is very limited
on the data it provides.
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that interferes with
seizure

Gil-López et al
(2020)

To determine the
efficacy of external
trigeminal nerve
stimulation in those
with focal drugresistant epilepsy

This study investigated
the effects of lowstimulation (40 Hz) and
high-frequency (130 Hz)
on three monkeys in
which Mesial temporal
lobe epilepsy was
induced

Total of 40 participants
were included
Subjects had a median of
15 seizures per month
and had tried a median
of 12.5 pharmacological
therapies
Participants were
randomized to external
trigeminal nerve
stimulation or usual
medical treatment (20
participants for
neurostimulation and 20
for control group) and
evaluated at 3, 6, and 12
months

the duration of the
seizures
High frequency was
shown to have no
effect

After one year, 50% of
the external trigeminal
nerve stimulation
responded to
treatment
The external trigeminal
nerve stimulation
group experienced a
decrease in seizure
frequency by 43.5%
from baseline

This study provided a
very small sample size
and was conducted on
monkeys; therefore,
another study needs to
be done with a larger
sample size and
examining people
undergoing
neurostimulation for
epilepsy
3
The group undergoing
external trigeminal nerve
stimulation experienced
a dramatic decrease in
their seizure frequency,
showing that
neurostimulation can be
an alternative treatment
for epilepsy

Temporal lobe
epilepsy responded
better than frontal lobe
epilepsy (55.56% vs
45.45%)

Participants were asked
to use the stimulation for
at least 8 hours a day
An external pulse
generator was used to
deliver external
trigeminal nerve
stimulation; intensity was
set at <10 mA, Frequency
120 Hz, pulse duration
250 μs, and duty cycle 30
sec on and 30 sec off
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Campos et al
(2017)

Investigate the
impact of two types
of exercise programs,
forced and voluntary,
in female Wistar rats
with pilocarpineinduced epilepsy

Total of 61 Wistar rats
were tested in this study
The Wistar rats were
divided into four groups:
control, epilepsy,
epilepsy with forced
exercise, and epilepsy
with voluntary exercise
Control= 20
Epilepsy= 14
Epilepsy with forced
exercise= 15
Epilepsy with voluntary
exercise= 12

The results showed
that voluntary exercise
exerts a positive effect
on females with
epilepsy

2
This study shows that
voluntary exercise has a
positive effect on
females
However, the study was
conducted on females
only, not both males and
females, and provides
information only about
how animals with
epilepsy respond to
exercise

An injection of 350
mg/kg was given to
induce seizures

Another study examining
the effects of exercise on
humans with epilepsy
would be of value.

Forced exercise group:
lasted for four weeks
with five sessions a week;
started from 16 m/min
and reaching 22 m/min in
the last week

Setkowicz &
Mazur
(2006)

To access the effect
of long-term physical
activity on
susceptibility to
frequent seizures

Voluntary exercise group:
animals were placed in a
cage with a voluntary
wheel for 30 days with
free success to food and
water
Total of twenty rats
participated in this study
This study consisted of
fifteen 3-day cycles; the
rats would run on the
treadmill the first day,
swim on the second day,
and rest on the third day
Pilocarpine was used to
induce seizure in the rats

Results showed that
regular physical
exercise decreases
susceptibility to
subsequently seizures

2
Although this study
suggests physical
exercise could reduce
seizure frequency, the
seizures experienced
were induced
Examining adults with
epilepsy, rather than
inducing seizures in
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Sondhi et al
(2020)

To access whether
the modified Atkins
diet and low
Glycemic Index
Therapy diet have
similar effects of the
Ketogenic diet for
drug-resistant
epilepsy

Total of 170 children
between the ages of 1
and 15 participated in
this study
Children were randomly
assigned for one of three
diet therapies: Ketogenic
diet, modified Atkins
diet, or the Low Glycemic
Index Therapy diet
Ketogenic diet: 52
Modified Atkins: 52
LGIT: 54

Roehl, FalcoWalter, Ouyang,
& Balabanov
(2019)

This study was
conducted to
evaluate the
modified ketogenic
diet on seizure
frequency, severity,
and quality of life

Total of 74 participants
between the ages 17 and
70 years old participated
in this study; majority
white (74%) and female
(73%) with focal epilepsy
(89%)
One group consumed 15
grams of carbohydrate
daily (MKD-15), while
another group consumed
50 grams of
carbohydrate daily (MKD50) for three months

Baby, Vinayan,
Pavithran, &
Grace Roy
(2018)

To analyze whether
the Ketogenic diet
can be beneficial to
children in South
India

Total of 74 children were
enrolled into a Ketogenic
diet program, with four
who could not complete
the process

One hundred and fiftyeight children
completed the trial
After the 24-weeks of
intervention, the
median change in
seizure frequency was
as follows:
Ketogenic diet: 66%
reduction
Modified Atkins: 45%
reduction
LGIT: 54% reduction

60% of participants
reported at least a 50%
reduction frequency in
their seizures, 76%
reported improvement
in their seizure
severity, and 87%
agreed that it improved
their quality of life
The results showed
that the MKD-15
improved the quality of
life in most participates
(95%), whereas the
MHD-50 only improved
some individual’s
quality of life (69%)
59.4% reported a
seizures reduction of
more than 50%

animals would provide
greater insight into the
seizure phenomena
3
This study suggests anticonvulsant effects in
children with varying
diets can influence
seizure symptoms, and
the ketogenic diet has
the biggest impact on
seizure reduction
This study implies there
is more than one diet
that has positive effects
on seizure frequency in
children

3
This study explores the
positive impact of the
ketogenic diet on seizure
frequency, severity, and
quality of life
The study had many
female participants
compared to male
participants. Examining
similar components with
the same age range, but
including an even
number of males and
females could explain the
occurrence of seizure
more accurately.
3
This study suggests the
Ketogenic diet can be a
beneficial and safe
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Baseline seizure
frequency was 5 or more
times a day for 52
children

He et al
(2013)

French et al.
(2017)

To investigate the
safety and efficacy of
transcutaneous
auricular vagus nerve
stimulation for the
treatment of
pediatric epilepsy

To evaluate efficacy
of CBD added to
antiepileptic drugs
(AED) for the
treatment of seizures
associated with
Lennox-Gastaut
syndrome.

The diet was continued
for a median duration of
10.43 months
Started with a total of 14
children with intractable
epilepsy participated in
this study; One child
dropped out after 8
weeks and the remaining
13 children completed
the 24-week study
without a change in the
medications

Baseline seizure
frequency was compared
with that after 8 weeks,
between weeks 9 to 16,
and between weeks 17 to
24
Participants were
randomized to receive 20
mg/kg/day of CBD oral
solution or a matched
placebo (86 CBD; 85
placebo) for a 14-week
study

25 reported seizure
reduction of at least
90%, with 6 children
being seizure-free

alternative therapy for
children with epilepsy

The results showed a
significant reduction in
seizure frequency
compared to baseline:

3

-31.83% reduction
after week 8
-54.14% reduction
between week 9 to 16
-54.21% reduction
between weeks 17 to
24

The results showed a
median seizure
frequency drop of
74/month
There was a significant
drop in seizure
frequency for those
who took the CBD oral
solution compared to
the placebo (44%
versus 22%)

86% of CBD oral
solution group
experienced adverse
effects after 4 weeks of

This study proves that
transcutaneous auricular
vagus nerve stimulation,
with adjuvant, individual
pharmacological therapy,
can be beneficial for
children

3

This study proves that
CBD is effective seizure
frequency when added to
AEDs
However, this study
shows that there are
many adverse effects
associated with CBD oral
solution
This study also focused
on individuals with
Lennox-Gastaut
syndrome, which is a
29

the study, while 69% of
the placebo group
experienced adverse
effects

Devinsky et al
(2016)

To evaluate whether
cannabidiol to
existing antiepilpsytic regimens
would be safe,
tolerated, and
efficient in treating
the clinical
manifestations of
epilepsy

214 individuals started
the trial; 162 participants
had at 12 weeks of
follow-up after first dose
were included in the
safety and tolerability
analysis and 137
participants were
included in the efficiency
analysis
Participants were given
oral cannabidiol 2 to 5
mg/kg per day, uptitrated until intolerance
or to a maximum dose of
25 mg/kg or 50 mg/kg
per day

There was one death in
the CBD group,
considered unrelated
to the study
128 out of the 162
participants (79%) in
the safety group
reported various
adverse effects,
including somnolence,
decreased appetite,
diarrhea, fatigue, and
convulsions
The median reduction
in motor seizures was
36.5%

severe form of epilepsy.
Other studies should be
done to see the results
on individuals without
Lennox-Gastaut
syndrome

3
The study shows that
cannabidiol can be
effective with reducing
seizure frequency, but
data is limited
Further research is need
to investigate cannabidiol
true efficacy in reduce
seizure frequency
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